A recent study highlights three rare complications associated with upadacitinib therapy in patients with inflammatory bowel disease. These findings contribute to the understanding of the drug's safety profile and its implications for patient management.
beyond the bowel three rare complications of upadacitinib therapy in inflammatory bowel disease
Original title: “Beyond the bowel: three rare complications of upadacitinib therapy in inflammatory bowel disease.”